Loading clinical trials...
Loading clinical trials...
Concurrent Carboplatin, Paclitaxel and Selenomethionine in Combination With Radiation for Patients With Unresectable Stage III Non-Small Cell Lung Cancer: A Phase II, Multi-Center Trial
Conditions
Interventions
selenomethionine
carboplatin
+3 more
Locations
1
United States
Roswell Park Cancer Institute
Buffalo, New York, United States
Start Date
October 1, 2006
Primary Completion Date
August 1, 2010
Completion Date
September 1, 2010
Last Updated
November 28, 2017
NCT06066138
NCT05692635
NCT05198830
NCT06498635
NCT07190248
NCT07336732
Lead Sponsor
Roswell Park Cancer Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions